USP33 and cancer: Similarly, lower expression of USP33 correlated with poorer survival in a range of other types of cancers, including breast cancer (BRCA, Fig. 3E and 3F), melanoma (SKCM, Fig. 3G) and acute myeloid leukemia (AML, Fig. 3H).